Human immunodeficiency virus type 1 (HIV-1) infects the central nervous system of adults and children. Little is known about HIV-1 infection of the fetal nervous system, or about the indirect effects of maternal HIV-1 infection on the developing fetal brain. There is currently no in vitro system or related animal model available which can satisfy the chief requirements to address pathogenetic Issues or to test anti-viral agents which may treat HIV-1 brain infection. The marked host species specificity of lentiviruses and the importance of viral-host cell interactions suggest that a model is required in which intact, differentiating, human fetal neural tissue can be infected by HIV-1 and/or exposed to potentially toxic viral or host derived factors. We have developed a model in which human second trimester fetal brain or retinal tissues are grown as xenografts in the anterior chamber of the eye in adult rats. These xenografts vascularize, establish a blood-brain-barrier, and differentiate into astroglial, microglial, and neuronal elements. We propose to establish and optimize conditions for infecting these human fetal neural tissues with HIV-1. Experiments are proposed employing cell free virus, virus infected lymphocytes and macrophages, and fetal neural explants infected in vitro prior to transplantation (Specific Aim 1). To determine the cellular localization and to analyze the course of the HIV-1 infection in these xenografts, we will use polymerase chain reaction (PCR), coupled with immunohistochemical and in situ hybridization techniques. This will identify which cell types (neuroectodermal or other) are infected, and the nature of Infection in each cell type (productive, restricted, or latent). Complementary studies will be performed using in vitro methods to segregate neuronal, astroglial, and microglial components, followed by re-aggregation of specific combinations of these cells, in the xenograft, to serve as a target for HIV-1 infection. (Specific Aim 2) We will evaluate the feasibility of of using this model to assess the efficacy and toxicity of antiviral agents which target HIV-1 infection of the nervous system (Specific Aim 3). Lastly we will use the xenograft model to determine the indirect effects on the developing nervous system of putative toxic factors of host cell or viral origin (Specific Aim 4).

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI032305-03
Application #
2067174
Study Section
AIDS and Related Research Study Section 2 (ARRB)
Project Start
1991-09-30
Project End
1995-01-31
Budget Start
1993-08-01
Budget End
1995-01-31
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Rochester
Department
Neurology
Type
Schools of Dentistry
DUNS #
208469486
City
Rochester
State
NY
Country
United States
Zip Code
14627
Sharer, L R; Saito, Y; Da Cunha, A et al. (1996) In situ amplification and detection of HIV-1 DNA in fixed pediatric AIDS brain tissue. Hum Pathol 27:614-7
Epstein, L G; Cvetkovich, T A; Lazar, E S et al. (1994) Human neural xenografts: progress in developing an in-vivo model to study human immunodeficiency virus (HIV) and human cytomegalovirus (HCMV) infection. Adv Neuroimmunol 4:257-60
Blumberg, B M; Gelbard, H A; Epstein, L G (1994) HIV-1 infection of the developing nervous system: central role of astrocytes in pathogenesis. Virus Res 32:253-67
Epstein, L G; Sharer, L R (1994) Neurological manifestations of perinatally acquired HIV-1 infection. Semin Pediatr Neurol 1:50-7
DiLoreto Jr, D; Epstein, L G; Lazar, E S et al. (1994) Cytomegalovirus infection of human retinal tissue: an in vivo model. Lab Invest 71:141-8
Epstein, L G; Gendelman, H E (1993) Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann Neurol 33:429-36
Cvetkovich, T A; Lazar, E; Blumberg, B M et al. (1992) Human immunodeficiency virus type 1 infection of neural xenografts. Proc Natl Acad Sci U S A 89:5162-6
Genis, P; Jett, M; Bernton, E W et al. (1992) Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med 176:1703-18